Inogen Inc (INGN) Releases Earnings Results, Beats Expectations By $0.05 EPS

Inogen Inc (INGN) reported quarterly earnings results on Thursday, Aug-4-2016. The company said it had a profit of $0.25 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.05. Analysts had a consensus of $0.20. The company posted revenue of $54.57 million in the period, compared to analysts expectations of $52.43 million. The company’s revenue was up 23.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.17 EPS.

Many Wall Street Analysts have commented on Inogen Inc. Inogen Inc was Resumed by JP Morgan to “Overweight” on Jul 13, 2016. Company shares were Reiterated by Stifel on May 10, 2016 to “Buy”, Firm has raised the Price Target to $ 52 from a previous price target of $46 .Company shares were Reiterated by Needham on May 10, 2016 to “Strong Buy”, Firm has raised the Price Target to $ 58 from a previous price target of $47 .

Inogen Inc closed down -0.26 points or -0.49% at $52.74 with 2,04,076 shares getting traded on Tusday. Post opening the session at $52.78, the shares hit an intraday low of $52.35 and an intraday high of $53.705 and the price fluctuated in this range throughout the day.Shares ended Tusday session in Red.

In a different news, on Jul 20, 2016, Matt Scribner (EVP, Operations) sold 4,102 shares at $50.50 per share price. According to the SEC, on Jul 20, 2016, Raymond Huggenberger (CEO) sold 20,747 shares at $50.57 per share price. On Apr 14, 2016, Brenton Taylor (EVP, Engineering) sold 6,500 shares at $48.00 per share price, according to the Form-4 filing with the securities and exchange commission.

Inogen Inc. is a medical technology company. The Company is engaged in developing manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company offers Inogen One systems such as Inogen One G3 and G2 that concentrate the air around the patients to offer a single source of supplemental oxygen. The Inogen One G3 and G2 have up to 4.5 and five hours of battery life respectively. The Company’s Inogen One G2 is effective for nocturnal use.

Inogen Inc

Leave a Reply

Inogen Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Inogen Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.